Multiple sclerosis (MS) is an immune-mediated…
emedicine.medscape.com
Superior drug survival, better efficacy over injectables, oral drugs
medpagetoday.com
Results of the phase 2 study suggest that an optimal dose can be found that will give maximal suppression of MS lesions without completely eradicating all B…
medscape.com
Finding the optimal dose and dosing interval to effect adequate B-cell depletion to significantly improve clinical outcome will not only minimise infection risk, but also save on cost, tremendously.